{
    "2019-03-12": [
        [
            {
                "time": "2019-03-12",
                "original_text": "BioNTech hires banks for IPO worth up to $800 million - sources",
                "features": {
                    "keywords": [
                        "IPO",
                        "BioNTech",
                        "$800 million"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare",
                        "biotech"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2019-03-12",
                "original_text": "Biontech stock offering could be worth as much as $800 million-sources",
                "features": {
                    "keywords": [
                        "stock offering",
                        "Biontech",
                        "$800 million"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare",
                        "biotech"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2019-03-12",
                "original_text": "Option trading opportunities in Pfizer & Sirius XM",
                "features": {
                    "keywords": [
                        "option trading",
                        "Pfizer",
                        "Sirius XM"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals",
                        "media"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "none",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-03-12",
                "original_text": "Pfizer's Herceptin Biosimilar Trazimera Gets FDA Approval",
                "features": {
                    "keywords": [
                        "Pfizer",
                        "Herceptin",
                        "FDA Approval"
                    ],
                    "sentiment_score": 0.95,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2019-03-12",
                "original_text": "Pfizer's (PFE) Kidney Cancer Drug Combo Gets EMA's Validation",
                "features": {
                    "keywords": [
                        "Pfizer",
                        "Kidney Cancer",
                        "EMA Validation"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2019-03-12",
                "original_text": "See what the IHS Markit Score report has to say about Pfizer Inc.",
                "features": {
                    "keywords": [
                        "IHS Markit Score",
                        "Pfizer"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "none",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-03-12",
                "original_text": "Health Care Sector Update for 03/12/2019: ZFGN, AKBA, HEXO, JNJ, PFE, ABT, MRK, AMGN",
                "features": {
                    "keywords": [
                        "Health Care Sector",
                        "ZFGN",
                        "AKBA",
                        "HEXO",
                        "JNJ",
                        "PFE",
                        "ABT",
                        "MRK",
                        "AMGN"
                    ],
                    "sentiment_score": 0.75,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "none",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-03-12",
                "original_text": "Why Novartis is a Top 10 SAFE International Dividend Stock (NVS)",
                "features": {
                    "keywords": [
                        "Novartis",
                        "SAFE",
                        "International Dividend Stock"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            }
        ]
    ]
}